- Report
- March 2024
- 190 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- March 2024
- 183 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- September 2023
- 100 Pages
Global
From €5743EUR$5,950USD£4,926GBP
- Report
- January 2024
- 200 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Report
- November 2023
- 180 Pages
Global
From €4729EUR$4,900USD£4,057GBP
- Report
- July 2023
- 156 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Clinical Trials
- April 2024
- 90 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Report
- August 2022
- 110 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- January 2022
- 200 Pages
Global
From €7239EUR$7,500USD£6,210GBP
- Report
- January 2022
- 200 Pages
Global
From €7239EUR$7,500USD£6,210GBP
- Report
- January 2022
- 60 Pages
Global
From €3813EUR$3,950USD£3,270GBP
- Report
- January 2022
- 60 Pages
Global
From €3813EUR$3,950USD£3,270GBP
- Drug Pipelines
- January 2019
- 60 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Report
- April 2024
- 82 Pages
From €3378EUR$3,500USD£2,898GBP
- Report
- August 2022
- 120 Pages
Global
From €4343EUR$4,500USD£3,726GBP
- Report
- August 2022
- 120 Pages
Global
From €4343EUR$4,500USD£3,726GBP
- Report
- August 2022
Global
From €763EUR$790USD£654GBP
- Report
- January 2023
- 146 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- March 2021
- 43 Pages
Global
€1272EUR$1,318USD£1,091GBP
The Angioedema Drug market is a subset of the Cardiovascular Drugs market, focusing on drugs used to treat angioedema, a condition characterized by swelling of the skin and mucous membranes. These drugs are typically used to reduce the severity of symptoms, such as hives, itching, and swelling of the face, lips, tongue, and throat. Commonly prescribed drugs include antihistamines, corticosteroids, and epinephrine. In some cases, angioedema drugs may be used in combination with other medications to provide a more comprehensive treatment plan.
The Angioedema Drug market is highly competitive, with a number of companies offering products to treat the condition. Some of the major players in the market include Sanofi, GlaxoSmithKline, Pfizer, Novartis, and Mylan. Other companies, such as Allergan, Merck, and Teva, also offer products for the treatment of angioedema. Show Less Read more